NCT02488421View on ClinicalTrials.gov

Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2

CompletedOBSERVATIONAL
Enrollment

38,122

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Non-valvular Atrial Fibrillation
Sponsors

Collaborators (1)

IMS Health
All Listed Sponsors
collaborator

IMS Health

OTHER

collaborator

OXON Epidemiology

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY